MetaADEDB 2.0 @ LMMD
Vyxeos
(HBQCEICSYDCGJG-SZXLQUARSA-N)
Structure
SMILES
COc1cccc2c1C(=O)c1c(C2=O)c(O)c2c(c1O)[C@@H](O[C@H]1C[C@H](N)[C@@H]([C@@H](O1)C)O)C[C@](C2)(O)C(=O)C.OC[C@H]1O[C@H]([C@H]([C@@H]1O)O)n1ccc(nc1=O)N
Molecular Formula:
C36H42N4O15
Molecular Weight:
770.736
Log P:
-0.2526
Hydrogen Bond Acceptor:
19
Hydrogen Bond Donor:
9
TPSA:
316.67
CAS Number(s):
1256639-86-7
Synonym(s)
1.
Vyxeos
External Link(s)
PubChem Compound11422859
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Febrile NeutropeniaFAERS: 17US FAERS
2Disease ProgressionFAERS: 13US FAERS
3NeutropeniaFAERS: 8US FAERS
4Ejection Fraction DecreasedFAERS: 7US FAERS
5Product administration errorFAERS: 7US FAERS
6Intentional dose omissionFAERS: 6US FAERS
7SepsisFAERS: 5US FAERS
8NauseaFAERS: 4US FAERS
9PancytopeniaFAERS: 4US FAERS
10Wrong technique in product usage processFAERS: 4US FAERS
11BradycardiaFAERS: 3US FAERS
12CellulitisFAERS: 3US FAERS
13Dermo-hypodermitisFAERS: 3US FAERS
14General physical health deteriorationFAERS: 3US FAERS
15InfectionFAERS: 3US FAERS
16ThrombocytopeniaFAERS: 3US FAERS
17AlopeciaFAERS: 2US FAERS
18Angle Closure GlaucomaFAERS: 2US FAERS
19Blast cell count increasedFAERS: 2US FAERS
20Blood copper increasedFAERS: 2US FAERS
21CytopeniaFAERS: 2US FAERS
22Device related infectionFAERS: 2US FAERS
23Drug ineffectiveFAERS: 2US FAERS
24EczemaFAERS: 2US FAERS
25ErysipelasFAERS: 2US FAERS
26Inappropriate schedule of product administrationFAERS: 2US FAERS
27Infusion site reactionFAERS: 2US FAERS
28Intentional product use issueFAERS: 2US FAERS
29Neutropenic sepsisFAERS: 2US FAERS
30PainFAERS: 2US FAERS
31Product storage errorFAERS: 2US FAERS
32Respiratory FailureFAERS: 2US FAERS
33VomitingFAERS: 2US FAERS
34Administration site extravasationFAERS: 1US FAERS
35Alanine Aminotransferase IncreasedFAERS: 1US FAERS
36Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
37AtaxiaFAERS: 1US FAERS
38Back PainFAERS: 1US FAERS
39BlindnessFAERS: 1US FAERS
40Blood lactate dehydrogenase increasedFAERS: 1US FAERS
41Bone painFAERS: 1US FAERS
42Brain natriuretic peptide increasedFAERS: 1US FAERS
43Cardiac dysfunctionFAERS: 1US FAERS
44CardiotoxicityFAERS: 1US FAERS
45Cerebrovascular accidentFAERS: 1US FAERS
46Chest PainFAERS: 1US FAERS
47CholestasisFAERS: 1US FAERS
48ChromaturiaFAERS: 1US FAERS
49DehydrationFAERS: 1US FAERS
50Disseminated Intravascular CoagulationFAERS: 1US FAERS
51Drug administered to patient of inappropriate ageFAERS: 1US FAERS
52Drug dose omissionFAERS: 1US FAERS
53Drug resistanceFAERS: 1US FAERS
54Enterococcal infectionFAERS: 1US FAERS
55EpistaxisFAERS: 1US FAERS
56ErythemaFAERS: 1US FAERS
57Escherichia sepsisFAERS: 1US FAERS
58Expired product administeredFAERS: 1US FAERS
59FasciitisFAERS: 1US FAERS
60FatigueFAERS: 1US FAERS
61FormicationFAERS: 1US FAERS
62Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
63Graft versus host disease in lungFAERS: 1US FAERS
64Graft versus host disease in skinFAERS: 1US FAERS
65Guillain-Barre SyndromeFAERS: 1US FAERS
66HeadacheFAERS: 1US FAERS
67HepatotoxicityFAERS: 1US FAERS
68HyperpyrexiaFAERS: 1US FAERS
69Hypertensive crisisFAERS: 1US FAERS
70HypotensionFAERS: 1US FAERS
71Incorrect drug administration durationFAERS: 1US FAERS
72Incorrect route of product administrationFAERS: 1US FAERS
73IntertrigoFAERS: 1US FAERS
74Lung consolidationFAERS: 1US FAERS
75MalaiseFAERS: 1US FAERS
76Medication ErrorFAERS: 1US FAERS
77Mental status changesFAERS: 1US FAERS
78MonocytosisFAERS: 1US FAERS
79MyocarditisFAERS: 1US FAERS
80No adverse eventFAERS: 1US FAERS
81OsteorrhagiaFAERS: 1US FAERS
82PneumoniaFAERS: 1US FAERS
83Poor quality product administeredFAERS: 1US FAERS
84Pulmonary congestionFAERS: 1US FAERS
85Pulmonary toxicityFAERS: 1US FAERS
86PurpuraFAERS: 1US FAERS
87Renal tubular necrosisFAERS: 1US FAERS
88Septic ShockFAERS: 1US FAERS
89Skin necrosisFAERS: 1US FAERS
90Skin reactionFAERS: 1US FAERS
91Skin toxicityFAERS: 1US FAERS
92Streptococcal urinary tract infectionFAERS: 1US FAERS
93Troponin TFAERS: 1US FAERS
94nervous system disorderFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.